Porton Advanced Solution
Latest round
- Series B
Last raised
- Aug 2022
Total raised
- $80M
Investors
- 11
About Porton Advanced Solution
a. Porton Advanced is a subsidiary of Porton Pharma Solutions, providing process development (PD), analytical development (AD), GMP manufacturing, and testing services to meet the therapeutic product needs at pre-clinical, clinical, and commercial stages of the clients. In August 2022, Porton Advanced Solution Ltd., CS Capital, Fosun Health Capital, Gortune Investment, HM Capital, Momentum Venture Capital, Ruilian Investment, and SDICTK. The company provides technology transfer, analytical development, process development, testing services, cGMP manufacturing, and discovery research, including proprietary technology licenses, across different cell and gene therapy segments.coli lysis, and a BIA two-step purification platform process, and more.
Who invested in Porton Advanced Solution
11 investors across 1 round
See all investors in Porton Advanced Solution
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Aug 21, 2022
Amount
$80M
Investors
Questions about Porton Advanced Solution
Who invested in Porton Advanced Solution?
Porton Advanced Solution has 11 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Porton Advanced Solution raised?
Porton Advanced Solution has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Porton Advanced Solution last raise money?
Porton Advanced Solution's most recent round on record is a Series B, in Aug 2022.
What does Porton Advanced Solution do?
Porton Advanced Solution is a pharmaceuticals company.
Where is Porton Advanced Solution headquartered?
Porton Advanced Solution is headquartered in Jiangsu, China.
Which VCs invest in companies like Porton Advanced Solution?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at Porton Advanced Solution's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Porton Advanced Solution? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.